Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)
Lauren C. Harshman, Victoria X. Wang, Anis A. Hamid, Gabriella Santone, Charles G. Drake, Michael A. Carducci, Robert S. DiPaola, Raina N. Fichorova, Christopher J. Sweeney
Research output: Contribution to journal › Article › peer-review
15Scopus
citations
Fingerprint
Dive into the research topics of 'Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)'. Together they form a unique fingerprint.